Cxbladder is an Accurate Genomic Urine Test for Bladder Cancer Surveillance
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in patients monitoring for recurrence.
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer in patients monitoring for recurrence.
Those that have already been treated for bladder cancer have unique monitoring needs to protect against the threat of recurrence.
Depending on your risk profile, doctors generally recommend a cystoscopy to examine the inside of the bladder and urethra every 3 to 12 months for several years after bladder cancer treatment.
If several years of surveillance have gone by and no cancer recurrence has been detected, a cystoscopy once a year may be enough, though the final decision rests with the physician and additional testing may be required depending on the nature and severity of the original cancer.
Cxbladder is a cutting-edge genomic urine test that quickly and accurately detects or rules out bladder cancer. The test combines clinical risk factor markers with genetic information, measuring five biomarker genes to detect the presence or absence of bladder cancer.
Cxbladder Monitor is a reliable non-invasive surveillance alternative designed to rule out the return of bladder cancer. The test provides accurate results with a single urine sample, reducing the need for frequent cystoscopies which can be both uncomfortable and inconvenient.
With proven performance in more than 20 peer-reviewed publications for bladder cancer detection and surveillance, Cxbladder is used by over 4,400 US urologists in more than 100,000 patients.
Browse our Clinical PublicationsCxbladder’s unique urine sample collection system is discrete, non-invasive, and easy-to-use, taking only minutes. Watch our instructions for use video to learn more.
To simplify and streamline the bladder cancer testing process, we are now offering Cxbladder in-home sampling for patients in the US. Participating patients have the option of submitting their urine sample in the comfort of their own home without the need to physically visit their urologist.
If you’re a patient monitoring for bladder cancer recurrence, we recommend you speak to your doctor and see if Cxbladder in-home sampling is right for you. Please note that Cxbladder in-home sampling systems must be ordered by your urologist. Speak to your doctor or contact us for more information.
We’re pleased to confirm that Cxbladder is covered by Medicare.
For questions about coverage please call the Cxbladder Assist Team at 1-855-CXBLADR (1-855-292-5237, option 1).
Cxbladder is an accurate and non-invasive surveillance alternative designed to rule out the return of bladder cancer. The test provides reliable results with a single urine sample, reducing the need for frequent cystoscopies which can be both uncomfortable and inconvenient.
Call us at 1-855-CXBLADR (1-855-292-5237)
Contact us to learn moreLast Updated: 16 Aug 2021 05:00 pm
Cxbladder is a cutting edge genomic urine test that quickly and accurately detects or rules out bladder cancer.
Learn more about the family of Cxbladder productsThe Cxbladder sampling process is quick and painless, taking only minutes.
Learn more about our sampling processOur Customer Service team are standing by to answer any queries you may have.
Contact us for more information